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ABSTRACT: Here we report evidence that new aminoquinoline
N-glycan fluorescent labels interfere with the release of core α(1−
6) fucose from N-glycans by bovine kidney α-L-fucosidase (BKF).
BKF is a commonly employed exoglycosidase for core α(1−6)
fucose determination. Molecular simulations of the bound and
unbound Fuc-α(1−6)-GlcNAc, where GlcNAc is situated at the
reducing end for all N-glycans, suggest that the reduced BKF
activity may be due to a nonoptimal fit of the highest populated
conformers in the BKF active binding site at room temperature.
Population analysis and free energy estimates suggest that an
enhanced flexibility of the labeled sugar, which facilitates
recognition and binding, can be achievable with extended
reaction conditions. We provide these experimental conditions
using a sequential exoglycosidase digestion array using high
concentrations of BKF.
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1. INTRODUCTION
N-Glycan fucosylation, with fucose linked via α(1−2), α(1−3),
α(1−4), α(1−6) linkages to Gal or GlcNAc residues, plays
major roles in plants, mammals, and other biological systems
and therefore can be exploited as tools for biomarker
discovery.1,2 They play important roles in cellular recognition
processes including blood transfusion reactions, selectin-
mediated leukocyte-endothelial adhesion, and host−microbe
interactions.2 Fucosylation is a critical quality attribute for
characterization of biotherapeutics such as monoclonal anti-
bodies and is becoming increasingly important for product
solubility, stability, pharmacokinetics, and immunogenicity
studies as well as for the regulation of safe and efficacious
drugs.3
N-Glycan analysis of glycoproteins involves glycoprotein
purification, denaturation, and enzymatic release of N-glycans
using Peptide-N-Glycosidase F (PNGase F).4 The N-glycans
can be fluorescently and stoichiometrically labeled with 2-
aminobenzamide (2-AB) and quantified using (ultra)-high
performance liquid chromatography (HPLC/UPLC),4 electro-
phoresis or by coupled liquid chromatography mass spectrom-
etry techniques.5 Exoglycosidase digestion assays6 in combina-
tion with databases such as Glycobase7 are performed to
structurally elucidate the glycans. In these arrays, individual
glycosidases remove terminal sugars with specificity for a
particular type of sugar, its anomeric configuration (α or β),
and its linkage to an adjacent sugar. For elucidation of N-glycan
core α(1,6) fucose, the enzyme bovine kidney fucosidase
(BKF) α(1−2,3,4,6) is most commonly used and has been
successfully employed on various different substrates including
N-glycans on glycoproteins IgG,6 IgM,8 and O-glycans,9
respectively.
New labels have recently been developed for improved
fluorescent labeling of released N-glycans for structural
analyses. Recently we described the use of an aminoquinoline
carbamate fluorescent label, 6-aminoquinolyl-N-hydroxy-
succinimidyl carbamate (AQC) in place of the traditional 2-
AB label (see Figure 1).10 This glycan label gives a 20-fold
improvement in fluorescent detection, compared to 2-AB.
Additionally, Waters’ RapiFluor-MS, also an aminoquinoline
glycan label, significantly overcomes the low MS ionization
efficiency of 2-AB and increases sensitivity beyond 100-fold
(see Figure 1).11 Despite the obvious analytical advances
aminoquinoline labels represent, they have also dramatically
altered the ease at which N-glycan core fucose can be
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enzymatically verified. In the present study, we show that BKF
has a significantly reduced ability to remove core α(1,6) fucose
from both AQC- or RapiFluor-MS-labeled N-glycans. We
further present molecular simulation of BKF’s active site to
explore the possible basis for its inability to efficiently act in the
presence of this new family of labels. We provide optimized
exoglycosidase digestion array conditions using stringent
conditions for the successful characterization of N-glycans.
2. MATERIALS AND METHODS
2.1. Materials and Chemistry
All chemical reagents and solvents were purchased from Sigma-
Aldrich (St. Louis, MO). Human IgG was purchased from
Sigma-Aldrich (I4506) for reduction, alkylation, and N-glycan
labeling with 2-AB and AQC as sources for 2-AB- and AQC-
labeled IgG N-glycans. Waters RapiFluor-MS glycan perform-
ance standard (186007983) was used as a source of RapiFluor-
MS-labeled IgG N-glycans. Recombinant PNGase F (P0709L),
ABS (α2−3,6,8,9 Neuraminidase A, P0722L, 20 mU/mL),
BTG (bovine testes β(1−3/4)-galactosidase, 2 mU/mL), GUH
(β-N-Acetylglucosaminidase S, 4 mU/ml), and BKF (α1−
2,3,4,6 Fucosidase, 2 mU/mL) were obtained from New
England Biolabs (Ipswich, Massachusetts). BTG (PZGKX-
5013, 5 U/mL), BKF (PZGKX-5006, 500 mU), and JBM
(PZGKX-5010, 150 U/mL) were purchased from Prozyme
(San Leandro, California). 10K Nanosep centrifugal devices
were purchased from Pall (Port Washington, NY) and
Hypersep Diol cartridges from Thermo Fischer Scientific
(Waltham, Massachusetts). Samples were analyzed on a Waters
Acquity H-Class UPLC instrument (Milford, MA).
2.2. Glycan Nomenclature
Colored Oxford nomenclature is used throughout, which
provides embedded linkage information.12 Structure abbrevia-
tions: all N-glycans have two core GlcNAcs; F at the start of the
abbreviation indicates a core-fucose α(1,6) linked to the inner
GlcNAc; Mx, number (x) of mannose on core GlcNAcs; Ax,
number of antenna (GlcNAc) on trimannosyl core; A2,
biantennary with both GlcNAcs as β(1,2) linked; B, bisecting
GlcNAc linked β(1,4) to β(1,4) mannose; Gx, number (x) of
β(1,4) linked galactose on antenna; Sx, number (x) of sialic
acids linked to galactose.
2.3. Preparation of 2-AB-Labeled N-Glycans from Human
IgG
A pool of released N-glycans from human IgG was prepared for
subsequent fluorescent labeling for visualization by UPLC
chromatography. For eight separate vials, reduction of human
IgG (525 μg in 100 μL phosphate buffer per vial, pH 7.4) was
afforded by addition of dithiothreithol (DTT, 40 μL per vial,
100 mM) by incubation at 700 rpm at 65 °C for 45 min.
Alkylation was afforded by treatment with iodoacetamide (IAA,
40 μL per vial, 20 mM) by incubation at rt for 1 h. PNGase F
(25 μL per vial) was added and incubated at 37 °C overnight.
The eight 10K Nanosep centrifugal devices were pre-
equilibrated with 50:50 water:acetonitrile, spun at 7000 rpm
for 10 min, and the supernatants were discarded. The N-glycan
mixtures were added to each spin cartridge and centrifuged at
12 000 rpm for 2 min collecting the purified supernatants. The
filters were washed with 800 μL of water by centrifugation at
12 000 rpm for 10 min, and the supernatants were pooled. Each
vial was pooled and vacuum-dried to give a stock solution of
unlabeled IgG N-glycans. A portion of the unlabeled glycans
were dissolved in 2-AB labeling mixture (350 mM 2-AB, 1 M
NaCNBH3 AcOH:DMSO 30:70), incubated at 70 °C at 700
rpm for 2 h. The reaction was quenched with 200 μL of 95%
MeCN. SPE Clean-up was performed using pre-equilibrated
HyperSep Diol cartridges (washing with 1 mL 95% MeCN,
100% H2O and 95% MeCN respectively), whereby the
supernatant was transferred to the HyperSep Diol cartridges,
washed with 2 × 1 mL of 95% MeCN, followed by elution with
2 × 1 mL of 20% MeCN. The supernatant was collected and
dried for UPLC chromatography.
2.4. Preparation of AQC-Labeled N-Glycans from Human
IgG
AQC-labeled N-glycans from IgG were denatured, alkylated,
and AQC-labeled according to the literature reference.13
2.5. Standard Exoglycosidase Digestion Conditions for
2-AB-, RapiFluor-MS-, and AQC-Labeled IgG N-Glycans
All enzymes were obtained from NEB ((Ipswich, Massachu-
setts). The 2-AB-, RapiFluor-MS-, and AQC-labeled glycans
were digested in a volume of 10 μL for 18 h at 37 °C in 50 mM
sodium acetate buffer, pH 5.5 using arrays of the following
enzymes: ABS (α2−3,6,8,9 Neuraminidase A, P0722L, final
concentration 2 mU/mL), BTG (bovine testes β(1−3/4)-
galactosidase, final concentration 400 U/mL), GUH (β-N-
Acetylglucosaminidase S, final concentration 800 U/ml), and
BKF (α1−2,3,4,6 Fucosidase, final concentration 800 U/mL).
After incubation, enzymes were removed by filtration through
10 kDa protein-binding EZ filters (Millipore Corporation). N-
Glycans were then analyzed by HILIC UPLC Chromatography.
Figure 1. 2-AB-, RapiFluor-MS-, and AQC-labeled N-glycans
structures with core α(1−6) fucose. The R group represents any
fluorescently labeled N-glycans and indicates the extension occurs via
β(1−4) glycosidic linkage to the N-acetyl glucosamine.
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Supporting Information (SI) Table S-1 contains the exoglyco-
side digestion array panel.
2.6. Optimized Exoglycosidase Digestion Conditions Using
AQC-Labeled IgG1 N-Glycans
All enzymes were obtained from either NEB ((Ipswich,
Massachusetts) or Prozyme ((San Leandro, California). The
AQC-labeled glycans were digested in a volume of 10 μL in a
sequential addition for 4 days at 37 °C in 50 mM sodium
acetate buffer, pH 5.5 using arrays of the following enzymes:
ABS (α2−3,6,8,9 Neuraminidase A, PZGK80040, final
concentration 0.5 U/mL), BTG (bovine testes β(1−3/4)-
galactosidase, PZGKX-5013, final concentration 1 U/mL),
GUH (β-N-Acetylglucosaminidase S, P0744L, final concen-
tration 800 U/mL), BKF (α1−2,3,4,6 Fucosidase, PZGKX-
5006, final concentration 4 U/mL), JBM ((α1−2,3,6
Mannosidase J, PZGKX-5010, final concentration 60 U/mL).
After incubation, enzymes were removed by filtration through
10 kDa protein-binding EZ filters (Millipore Corporation). N-
Glycans were then analyzed by HILIC UPLC Chromatography.
SI Table S-2 contains the exoglycosidase digestion array panel.
2.7. Ultra Performance Liquid Chromatography (UPLC)
with Fluorescence Detection (FLD)
Separation of 2-AB- and aminoquinoline-labeled N-glycans was
carried out by UPLC with fluorescence detection on a Waters
ACQUITY UPLC H-Class instrument consisting of a binary
solvent manager, sample manager and fluorescence detector
under the control of Empower 3 software (Waters, Milford,
MA). The HILIC separations were performed using a Waters
Ethylene Bridged Hybrid (BEH) Glycan column (150 × 2.1
mm i.d. 186004742, 1.7 μm BEH particles) with 50 mM
ammonium formate (pH 4.4) as solvent A and MeCN as
solvent B. The column was fitted with an ACQUITY in-line 0.2
μm filter. The separation was performed using a linear gradient
of 70−53% MeCN at 0.56 mL/min in 30 and 16.5 min,
respectively, for 2-AB- and aminoquinoline-labeled N-glycans.
An injection volume of 10 μL prepared in 70% v/v MeCN was
used throughout. Samples were maintained at 5 °C prior to
injection, and the separation temperature was 40 °C. The FLD
excitation/emission wavelengths were λex = 330 nm (2-AB),
245 nm (aminoquinline) and λem = 420 nm (2-AB), 395 nm
(aminoquinoline), respectively. The system was calibrated
using an external standard of hydrolyzed and 2-AB-labeled
glucose oligomers to create a dextran ladder, as described
previously.14 A fifth-order polynomial distribution curve was
fitted to the dextran ladder to assign glucose unit (GU) values
from retention times (using Empower software from Waters).
2.8. Computational Methods
Because of the different chemical nature of the groups in the
fluorescently labeled Fuc-α(1−6)-GlcNAc, we used a combi-
nation of empirical force fields to run the MD calculations,
namely, GLYCAM06-h115 for the sugar moiety, and the
Generalized AMBER Force Field (GAFF)16 for the fluorescent
labels and for the open GlcNAc in the 2-AB tagged glycan. The
structures of the open GlcNAc, AQC, and 2-AB labels were
generated and saved in PDB format using the academic version
of Schrödinger Maestro v.10.7.015.17 The point charges for
these groups have been calculated with USCF Chimera
v.1.11.2,18 and were manually rescaled to guarantee the
neutrality of the whole system. A library file of GAFF
parameters and a f rcmod file were generated using the tleap
module of AMBER 12.19 Topology file and coordinate files for
the labeled glycans were also generated with tleap and solvated
with the TIP3P20 water model. To ensure exhaustive
conformational sampling, four different starting conformations
of the α(1−6) glycosidic linkage, which included gt, gg, and tg
conformers, were used as starting points for the MD
simulations.
2.8.1. Molecular Dynamic Simulations. The minimiza-
tions and MD simulations were performed using AMBER 12.
Production for each of the four starting conformations was set
to 100 ns, for a cumulative sampling time of 400 ns for both
labeled glycans. Energy minimizations through 500 k cycles of
steepest descent with a restraint of 5 kcal/mol*Å2 applied to all
heavy atoms. For the 2-AB-labeled glycans, an additional 500k
unrestrained minimization was carried out, to relax the acyclic
GlcNAc conformation. Following the minimization stage(s),
the system was heated from 5 to 298.5 K over 50 ps and then
equilibrated at 300 K for 250 ps. This step was followed by a
100 ns production run. The resultant trajectory files were
stripped of water using the ptraj module of AMBER 12. The
trajectories were visualized using VMD v.1.9.3 beta 1,21 and the
highest populated conformers identified in terms of the torsion
angle values and relative populations over 100 ns.
2.8.2. Sequence Alignments and Homology Model.
The PDBe search engine available through the EMBL European
Bioinformatics Institute (EBI) Web site was used to select
protein structures with sequence identity higher than 30%
relative to BKF (GenBank reference: AAI12589.1). Thermotoga
maritima alpha fucosidase (TMF, 1ODU PDBid22) with 35.7%
identity was selected as template, and two sequence alignments
were used to build BKF homology models, one obtained with
the program MODELER v.9.15,23 which was also used for the
structure generation and scoring, and one with Clustal
Omega.24 A total of 10 BKF 3D structures were visually
analyzed by structural alignment to their TMF template using
PyMol v.1.4.1.25 The most suitable structures were selected in
terms of the conservation of the position of critical residues,
such as the nucleophile and assisting base relative to the TMF
template and the discrete optimized protein energy (DOPE)
score.
2.8.3. MD Conformational Analysis of the AQC-
Labeled Fuc-α(1−6)-GlcNAc. The conformations visited
during the 100 ns production from one of the MDs can be
described in terms of the values of the α(1−6) linkage ψ, φ, and
ω torsions. A typical distribution is shown in SI Figure S-3 as an
example. Conformational propensity was determined based on
bins of width of ±40°, centered around the average values of
the highest populated conformers identified through graphs as
the one shown in SI Figure S-3. The torsion angle values and
relative populations of the four highest populated AQC-tagged
sugars are shown SI Table S-3.
2.8.4. MD Conformational Analysis of the 2-AB-
Labeled Fuc-α(1−6)-GlcNAc. The same approach was
taken to perform the conformational analysis of the 2-AB-
labeled glycan. A typical distribution is shown in SI Figure S-4
as an example. The four highest populated conformers
identified during the cumulative 400 ns simulation of the 2-
AB-labeled glycan are shown in SI Table S-4. All other
conformers not included in the table have a population of less
than 3%.
2.8.5. Potential Structure of the 2-AB-Labeled Glycan
in Complex with BKF. The structural alignment of the fucose
cocrystallized with TMF to the ring atoms of the fucose of the
highest populated conformers obtained through MD was used
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as a method to establish the potential fit of the labeled glycan
into the BKF binding site. As shown in SI Figure S-5 panels C
and E, conformers 1 (40.3% populated) and 3 (6.7%
populated) have the 2-AB label pointing out of the active
site, while conformers 2 (36.5%) and 4 (5.8%), shown in SI
Figure S-5 panels D and F, have the label pointing toward the
inside of the enzyme, suggesting that these conformation would
not bind.
2.8.6. DFT Conformational Analysis of the AQC-
Labeled Fuc-α(1−6)-GlcNAc. All DFT calculations were
run with NWChem v.6.3,26 at the B3LYP/6-311G** level of
theory.27 A DFT analysis of the relative stability of the different
conformers identified through the MD simulation was carried
out to verify the identity of such conformers as local energy
minima and ultimately as a validation of the force field
combination chosen to describe the fluorescently labeled
glycans. During such analysis, we took into consideration that
while the MD was ran in explicit solvent, all DFT calculations
were ran in vacuo, which could alter considerably the relative
stabilities of some conformations, due to the formation of
internal hydrogen bonds, not populated (or relevant) in bulk
water.28
Calculations were run at the B3LYP/6-311G** level of
theory. Conformer 2 from the MD simulations was not stable
in vacuo, because the internal hydrogen bonds formed in the
geometry optimization stabilizes the structure. The glycosidic
bond has to rotate to allow this hydrogen bonding to occur.
The DFT B3LYP/6-311G** global minimum corresponds to
the highest populated conformer obtained through MD, i.e.
conformer 1. The difference in conformer 2 from MD and the
optimized conformer (labeled conformer A) from DFT can be
seen in SI Figure S-6. Conformers 1, 3, and 4 were identified as
minima by DFT, and their relative energies are shown in SI
Table S-5.
2.8.7. DFT Conformational Analysis of the 2-AB-
Labeled Fuc-α(1−6)-GlcNAc. The DFT geometry optimiza-
tion of the different conformers obtained for the 2-AB-labeled
glycan through the MD simulations was carried out with the
same protocol used in the case of the AQC-labeled glycan.
Conformer 1 from MD simulations was not stable in vacuo,
Figure 2. HILIC UPLC chromatograms showing comparison of core α(1,6) fucose removal by using BKF for (A) 2-AB, (B) RapiFluor-MS, and (C)
AQC (aminoquinoline carbamate)-labeled IgG N-glycans previously digested with sialidase (ABS), galactosidase (BTG), and hexosaminidase
(GUH). Efficient reduction of α(1−6) core linked fucose residues for 2-AB-labeled N-glycans is depicted with an arrow showing the reduction of
glycan structure FM3 in panel A.1 to M3 shown in panel A.2. Inefficient reduction of α(1−6) core linked fucose residues for RapiFluor-MS- and
AQC-labeled N-glycans, with little/no reduction in the corresponding M3 glycan structure, are depicted with an arrow with a red cross for panels B
and C. UPLC chromatograms showing the full exoglycosidase digestion arrays are found in SI Figure S-2. The experimental conditions for the
exoglycosidase digestion were followed according to SI Table S-1. ABS (α2−3,6,8,9 Neuraminidase A, releases α(2−3,6,8,9) linked nonreducing
terminal sialic acids), BTG (β1−3,4 Galactosidase, releases α(1−3,4) linked nonreducing terminal galactose, GUH (β-N-Acetylglucosaminidase S,
releases β(1−2,3,4,6) linked nonreducing N-acetyl glucosamine), and BKF (α1−2,3,4,6 Fucosidase, releases α(1−2,3,4) linked nonreducing terminal
fucose. Colored Oxford nomenclature is used for glycan designation, and a legend is provided in the figure.12
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with the DFT B3LYP/6-311G** global minimum correspond-
ing to a populated conformer identified from MD simulations,
listed as conformer B in SI Table S-6. Conformer B has a
relative population of 2.1. SI Figure S-7 shows the internal
hydrogen bonding that stabilizes conformer B in vacuo and the
difference in torsion angles between conformer 1 (from MD)
and conformer B. Conformers 2, 3, and 4 were identified as
minima, and their relative energies were calculated, as shown in
SI Table S-6.
3. RESULTS AND DISCUSSION
We first explored if the presence of aminoquinoline labels
affected the performance of exoglycosidase arrays. RapiFluor-
MS- or AQC-labeled immunoglobulin G (IgG) N-glycans were
sequenced using standard exoglycosidase digestion conditions
and compared to 2-AB-labeled IgG N-glycans as a control (see
experimental details and SI Figure S-1, Table S-1). As shown in
Figure 2, negligible removal of core α(1−6) fucose was
observed for RapiFluor-MS- and AQC-labeled IgG N-glycans,
compared to 2-AB-labeled IgG N-glycans. In contrast, complete
sialidase, galactosidase, and hexosaminidase reactions were
observed for each of the three labels. Thus, only removal of
core α(1−6) fucose by BKF was adversely affected by the
presence of an aminoquinoline label.
Reaction conditions were optimized to create an exoglyco-
sidase array fully capable of sequencing aminoquinoline-labeled
N-glycans (including core α(1−6) fucose removal). This
involved the use of sequential enzyme digests (SI Table S-2),
higher BKF concentrations, and longer reaction times. Using
this approach, it was possible to improve BKF removal of core
α(1,6) fucose from AQC-labeled N-glycans (see experimental
details and SI Figure S-2, Table S-2). However, this array
procedure took 3−4 days to execute, compared to ∼18 h with
2-AB-labeled glycans. These data illustrate that inhibition of
BKF by aminoquinoline labels is not exhaustive, suggesting that
creation of BKF variants that more efficiently remove core
α(1,6) fucose might be plausible. In the meantime, these
conditions provide analysts a procedure for sequencing
aminoquinoline-labeled N-glycans in an extended protocol.
To understand the molecular basis for the reduced ability of
BKF to remove core α(1,6) fucose from for AQC-labeled N-
glycans, we used a combination of molecular simulation
techniques, namely, molecular dynamics (MD), ab initio
density-functional theory (DFT), and homology modeling, to
study the recognition of the AQC- and 2-AB-labeled Fuc-α(1−
6)-GlcNAc, designed to assess the structural complementarity
of the BKF binding site with the labeled sugar conformations at
300 K, as well as the intrinsic conformational flexibility of the
labeled sugars. Because of the lack of structural data on BKF,
we built 3D models of the complexes with the AQC- and 2-AB-
labeled minimum binding motif Fuc-α(1−6)-GlcNAc via
homology modeling. The BKF model was based on the
structure of T. maritima α-L-fucosidase cocrystallized with
fucose (PDBid 1ODU),23 with which BKF shares 36%
sequence identity.24 The cocrystallized fucose was used as
reference for the structural alignment of the AQC- and 2-AB-
tagged Fuc-α(1−6)-GlcNAc conformers obtained through
molecular dynamics (MD) in solution. We ran a collective
400 ns MD simulation for each labeled sugar, based on four
independent and uncorrelated 100 ns trajectories at 300 K and
1 bar. Parameters for the were set based on a GLYCAM0615/
GAFF16 force field scheme. The highest populated conformers
were verified as energy minima by hybrid DFT (B3LYP)
calculations. Further details on the computational method and
data are included in the experimental section (see Computa-
tional Methods, SI Figures S-3−S-6, Tables S-3−S-6).
The conformational analysis of the unbound AQC-labeled
Fuc-α(1−6)-GlcNAc shows that only four conformers are
significantly populated (>10%) in solution, with the highest
populated at 40%, see SI Table S-3. These conformers are
characterized by distinct values of the α(1−6) glycosidic linkage
ψ and ω angles, which determine the spatial orientation of the
structurally rigid AQC group and of the O-4 on the GlcNAc
residue where the N-glycan GlcNAc-trimannose group are
attached to, see Figure 3, panel A.
Structural alignment of the highest populated AQC-labeled
conformers onto the fucose in the BKF binding site, shows that
only the conformation with a relative population of 10% over
400 ns, fits in the binding site without major steric clashes for
the AQC tag and for the remainder of the sugar linked to the
O-4 on the GlcNAc residue. As shown in Figure 3C−F, because
of the narrow structure of the BKF binding site, the three
highest populated conformers are a very tight fit, not only for
the AQC tag but also for the remainder of the glycan at
position O4 of GlcNAc residue. The relative populations
Figure 3. Panel A, structural alignment of the four highest populated
conformers obtained from the analysis of a cumulative 400 ns MD of
the AQC-labeled Fuc-α(1−6)-GlcNAc. Panel B, structural alignment
of the four highest populated conformers on to the fucose in the BKF
3D model binding site. Panels C, D, E, and F, close up of the spatial
orientation of the different conformers, with populations 40%
(yellow), 25% (purple), 11% (cyan), and 10% (green), respectively.
The GlcNAc O4, where the N-glycan chain is attached, is shown as a
red sphere.
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obtained through MD suggest that between the optimally
fitting (10%) and the highest populated conformer (40%), the
free energy (ΔG) barrier is relatively low, i.e. ΔG = +3.4 kJ/mol
(1.4 kT). This is in agreement with the experimental
observation that digestion can be brought to completion by
stressing the reaction conditions, for example, through
prolonged reaction time or increased fucosidase concentrations.
In case of the 2-AB-labeled sugar, because of the characteristic
acyclic structure of the GlcNAc, the conformational dynamics
visits only two significantly populated conformations through
400 ns, see SI Table S-2, with comparable relative populations,
i.e. 40% and 36%. Only one of the two has a near perfect fit in
the BKF binding site, and the almost equal population
distribution, due to the intrinsic flexibility of the acyclic
GlcNAc, corresponds to ΔG = +0.3 kJ/mol (0.5 kT),
suggesting a high degree of conformational flexibility at room
temperature that would facilitate substrate recognition and
binding.
■ CONCLUSIONS
Biochemical evidence is provided that core α(1,6) fucose
removal in the presence of aminoquinoline labels such as AQC
or RapiFluor-MS for glycan characterization is hindered using
standard exoglycosidase digestion conditions. Optimized
experimental conditions using high concentrations of BKF
and longer reaction times are presented to show core α(1,6)
fucose removal in the presence of AQC. This biochemical data
is supported by our computational model that suggest a
rationale for the poor ability of BKF to remove α(1,6) fucose
from aminoquinoline labeled N-glycans. This rationale is
essentially based on the low degree on intrinsic flexibility of
the aminoquinoline group. MD simulations show that only four
distinct conformations of the AQC-labeled sugar are signifi-
cantly populated in solution (>10%). Based on the structure of
BKF obtained from homology modeling, only one of these
conformers fits in the binding site without major steric clashes
with the protein. We acknowledge that such experimental
conditions may not be suitable in analytical applications where
cost and/or time are significant factors. Thus, future work will
involve attempts to improve BKF’s ability to hydrolyze core
fucose from aminoquinoline-labeled N-glycans using structure-
guided mutagenesis strategies.
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